This course provides students with the fundamentals necessary to understand and contribute to financial assessments for biopharmaceutical processes, technologies, and infrastructure. The course will cover the basic calculations used in financial strategy, analysis, and executive decision making, as well as review best-practices for engineers to contribute meaningfully to these assessments in an industry setting. A student successfully completing this course will understand cost assessment, net present value analysis, cash flow principles, sensitivity analysis, modeling, and application of these principles in informing company leadership.
AlS 350/MEB 350
Apply now! There is still time to meet our December 15 Priority Deadline!